ArticleThe Journal of clinical investigation2026

AAV-mediated gene therapy in a model of SLC13A5 citrate transporter disorder rescues epileptic and metabolic phenotypes.

Lauren E Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.